A recovery of the long‐term potentiation in the hippocampus was observed, where the treatment with CBGA and CBDA also restored the physiological expression level of TRPM7, a receptor channel involved in neurodegenerative diseases. Here, TRPM7 is linked to neurodegenerative disease.